Abstract
Alzheimer’s disease (AD) is one of the major neurodegenerative diseases affecting almost 28 million people around the globe. It consistently remains one of the major health concerns of present world. Due to the clinical limitations like severe side effects of some synthesized drugs, alternative forms of treatments are gaining global acceptance in the treatment of AD. Neuroprotective compounds of natural origin and their synthetic derivatives exhibit promising results with minimal side effects and some of them are in their different phases of clinical trials. Alkaloids and their synthetic derivatives form one of the groups which have been used in treatment of neurodegenerative diseases like AD. We have further grouped these alkaloids into different sub groups like Indoles, piperdine and isoquinolines. Polyphenols form another important class of natural compounds used in AD management.
Keywords: Alkaloids, polyphenols, Alzheimer’s disease, neuroprotective function, Indoles, piperdine, isoquinolines, dementia, Physostigma venenosum, Rutaecarpine.
CNS & Neurological Disorders - Drug Targets
Title:An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease
Volume: 11 Issue: 8
Author(s): Ishfaq Ahmed Sheikh, Riyasat Ali, Tanveer A. Dar and Mohammad Amjad Kamal
Affiliation:
Keywords: Alkaloids, polyphenols, Alzheimer’s disease, neuroprotective function, Indoles, piperdine, isoquinolines, dementia, Physostigma venenosum, Rutaecarpine.
Abstract: Alzheimer’s disease (AD) is one of the major neurodegenerative diseases affecting almost 28 million people around the globe. It consistently remains one of the major health concerns of present world. Due to the clinical limitations like severe side effects of some synthesized drugs, alternative forms of treatments are gaining global acceptance in the treatment of AD. Neuroprotective compounds of natural origin and their synthetic derivatives exhibit promising results with minimal side effects and some of them are in their different phases of clinical trials. Alkaloids and their synthetic derivatives form one of the groups which have been used in treatment of neurodegenerative diseases like AD. We have further grouped these alkaloids into different sub groups like Indoles, piperdine and isoquinolines. Polyphenols form another important class of natural compounds used in AD management.
Export Options
About this article
Cite this article as:
Ahmed Sheikh Ishfaq, Ali Riyasat, A. Dar Tanveer and Amjad Kamal Mohammad, An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080010
DOI https://dx.doi.org/10.2174/1871527311211080010 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heart Failure Pharmacotherapy and Supports in the Elderly - A Short Review
Current Cardiology Reviews Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics How and When Environmental Agents and Dietary Factors Affect the Course of Alzheimers Disease: The “LEARn” Model (Latent Early-Life Associated Regulation) May Explain the Triggering of AD
Current Alzheimer Research Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Current Pharmaceutical Design Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Current Alzheimer Research Synaptic Plasticity, Dementia and Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Adult Stem Cell Transplantation in Stroke: Its Limitations and Prospects
Current Stem Cell Research & Therapy The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Inflammation and Parkinsons Disease
Current Drug Targets - Inflammation & Allergy Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Can Diet and Physical Activity Limit Alzheimer's Disease Risk?
Current Alzheimer Research Editorial [Hot Topic: Drug Targets in Alzheimers Disease (Executive Editors: G. Munch and G. Stuchbury)]
Current Pharmaceutical Design A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science Development of Subjective Cognitive Decline
Neuroscience and Biomedical Engineering (Discontinued) Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets In Silico Search and Toxicology Prediction of Novel Potential β-Secretase Inhibitors in Alzheimers Disease
Current Bioactive Compounds Sleep and Antidepressant Treatment
Current Pharmaceutical Design Drug Treatment of Metabolic Syndrome
Current Clinical Pharmacology